Class IITerminatedD-1040-2017
Drug recall · August 9, 2017
Testosterone Cypionate + Progesterone recall
Why: CGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Testosterone Cypionate + Progesterone, 200 mg/ 2.5 mg/mL ,10 mL amber glass vials, Rx Only, Compounded by AXIA Pharmaceutical, Los Angeles, CA 90025
- Lots / codes
Lot # 03022017+44906; BUD 08/29/17
- Quantity
- 120 vials
- Company
- Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical, Los Angeles, CA
- Distribution
- There were only one customer in California
- Initiated
- July 12, 2017 · Voluntary: Firm initiated
- Classified
- July 31, 2017
- Reported
- August 9, 2017
- Ended
- January 14, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Testosterone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.